Comparable stake leader
VANGUARD PORTFOLIO MANAGEMENT LLC
SEC ownership of HAEMONETICS CORP
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000313143.
Disclosed value leader
Neuberger Berman Group LLC
Comparable rows
6/50
Latest evidence
30 Oct 2026
- Public ticker
- HAE on NYSE
- Parsed ownership sources
-
13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
VANGUARD PORTFOLIO MANAGEMENT LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
6 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
VANGUARD PORTFOLIO MANAGEMENT LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Oct 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000313143
- Issuer location
- Boston, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of HAEMONETICS CORP (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD PORTFOLIO MANAGE...
Disclosed value leader
Neuberger Berman Group LLC
Comparable rows
6/50
Latest evidence
30 Oct 2026
13F
13D/G
3/4/5
Lead comparable stake: 5.6%
44 rows are not safely comparable across share classes.
13D/G row: VANGUARD PORTFOLIO MANAGEMENT LLC
Showing 1-8 of 50 holder rows.
Quick read
VANGUARD PORTFOLIO MANAGEMENT LLC leads the comparable SEC ownership view at 5.6%.
6 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD PORTFOLIO MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
VANGUARD PORTFOLIO MANAGEMENT LLC
5.6%
VANGUARD CAPITAL MANAGEMENT LLC
5.3%
AQR CAPITAL MANAGEMENT LLC
5%
WELLINGTON MANAGEMENT GROUP LLP
4.6%
T. Rowe Price Investment Manageme...
4.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
13D/G
Company · Vanguard Portfolio Management
|
5.6%
Reported 13D/G
· 31 Mar 2026
|
$263,378,571
2,501,221 shares
|
— | 30 Sep 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
13D/G
Company · Vanguard Capital Management
|
5.3%
Reported 13D/G
· 31 Mar 2026
|
$215,423,793
2,045,810 shares
|
— | 30 Sep 2026 |
| AQR CAPITAL MANAGEMENT LLC |
13D/G
|
5%
Reported 13D/G
· 30 Jun 2026
|
$169,986,675
2,266,489 shares
|
-$67,246,125 | 30 Jun 2026 |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
|
4.6%
Reported 13D/G
· 30 Jun 2025
|
$165,537,761
2,203,351 shares
|
-$36,448,193 | 30 Jun 2025 |
| T. Rowe Price Investment Management, Inc. |
13D/G
|
4.4%
Reported 13D/G
· 31 Mar 2025
|
$135,949,632
2,195,569 shares
|
$0 | 31 Mar 2025 |
| Capital Research Global Investors |
13D/G
|
3.1%
Reported 13D/G
· 31 Mar 2025
|
$97,667,840
1,577,323 shares
|
$0 | 31 Mar 2025 |
| Neuberger Berman Group LLC |
13F
Company
|
—
denominator unverified
|
$366,662,995
3,481,774 shares
|
— | 30 Sep 2026 |
| ARIEL INVESTMENTS, LLC |
13F
Company
|
—
denominator unverified
|
$228,877,447
2,173,575 shares
|
— | 30 Sep 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$101,148.
Buys
$0
Insiders: 0
Sells
$101,148
Insiders: 1
Net
-$101,148
Shares: -836
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 836
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 836 | $0 | $101,148 | -$101,148 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 24 reporting-owner rows connected to HAEMONETICS CORP. Open a relationship link for the CIK-to-CIK filing trail.
Rows
24
Largest Forms 3/4/5 holder
Christopher Simon
Net 12M change
-$101.15K
Full value: -$101,148 · USD · 12-month changeLatest report
11 Nov 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Christopher Simon | President & CEO, Director | $25,063,517 | Mixed | 15 May 2026 | ||
| Roy Galvin | EVP, Chief Commercial Officer | $4,191,466 | Median | 30 Oct 2026 | ||
| Michelle L. Basil | EVP and General Counsel | $3,879,202 | Mixed | 15 May 2026 | ||
| James Darecca | EVP, Chief Financial Officer | $3,068,463 | Mixed | 15 May 2026 | ||
| Josep Llorens | EVP, Global Manufacturing | $2,961,886 | Mixed | 28 May 2024 | ||
| William P. Mr. Burke | EVP, Chief Financial Officer | $2,616,839 | Mixed | 23 Aug 2021 | ||
| Laurie A. Miller | SVP, Human Resources | $2,310,027 | Mixed | 05 Jun 2026 | ||
| Robert E. Abernathy | Director | $2,063,925 | Mixed | 24 Jul 2026 | ||
| Mark W. Kroll | Director | $2,047,125 | Mixed | 24 Jul 2026 | ||
| Anila Lingamneni | EVP, Chief Technology Officer | $1,919,790 | Filing P/S | 11 Jul 2024 | ||
| Charles J. Dockendorff | Director | $1,868,308 | Mixed | 24 Jul 2025 | ||
| Frank Chan | EVP, Chief Operating Officer | $1,856,272 | Mixed | 15 May 2026 | ||
| Catherine M. Burzik | Director | $1,688,493 | Mixed | 05 Aug 2022 | ||
| Stewart W. Strong | President, Global Hospital | $1,658,565 | Filing P/S | 26 Jul 2024 | ||
| Ellen M. Zane | Director | $1,643,325 | Mixed | 24 Jul 2026 | ||
| Chad M. Nikel | President, Global Plasma & BC | $1,497,657 | Mixed | 06 Aug 2021 | ||
| Claire Pomeroy | Director | $1,455,750 | Mixed | 24 Jul 2026 | ||
| Michael J. Coyle | Director | $1,344,900 | Mixed | 24 Jul 2026 | ||
| Lloyd Emerson Johnson | Director | $1,160,325 | Mixed | 24 Jul 2026 | ||
| Diane M. Bryant | Director | $724,800 | Mixed | 24 Jul 2026 |
Recent insider transactions for HAEMONETICS CORP
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Farris Maryanne Maunsell | HAE | Common Stock | Sale | -12.6% | -$101,148 | $120.99 | -836 | 5,828 | 11 Nov 2026 | Direct |
| Farris Maryanne Maunsell | HAE | Common Stock | Tax liability | -20.6% | -1,724 | 6,664 | 11 Nov 2026 | Direct | ||
| Farris Maryanne Maunsell | HAE | Common Stock | Options Exercise | 34.4% | 2,146 | 8,388 | 11 Nov 2026 | Direct | ||
| Farris Maryanne Maunsell | HAE | Non-qualified Stock Option (Right to Buy) | Options Exercise | -85.7% | -2,146 | 357 | 11 Nov 2026 | Direct | ||
| Roy Galvin | HAE | Common Stock | Tax liability | -0.37% | -146 | 39,805 | 30 Oct 2026 | Direct | ||
| Martin D. Madaus | HAE | Common Stock | Award | 2,538 | 2,538 | 24 Jul 2026 | Direct | |||
| Ellen M. Zane | HAE | Common Stock | Award | 13.1% | 2,538 | 21,911 | 24 Jul 2026 | Direct | ||
| Claire Pomeroy | HAE | Common Stock | Award | 15% | 2,538 | 19,410 | 24 Jul 2026 | Direct | ||
| Mark W. Kroll | HAE | Common Stock | Award | 10.2% | 2,538 | 27,295 | 24 Jul 2026 | Direct | ||
| Lloyd Emerson Johnson | HAE | Common Stock | Award | 19.6% | 2,538 | 15,471 | 24 Jul 2026 | Direct | ||
| Michael J. Coyle | HAE | Common Stock | Award | 16.5% | 2,538 | 17,932 | 24 Jul 2026 | Direct | ||
| Diane M. Bryant | HAE | Common Stock | Award | 35.6% | 2,538 | 9,664 | 24 Jul 2026 | Direct | ||
| Robert E. Abernathy | HAE | Common Stock | Award | 10.2% | 2,538 | 27,519 | 24 Jul 2026 | Direct | ||
| Farris Maryanne Maunsell | HAE | Common Stock | Tax liability | -3.98% | -259 | 6,242 | 05 Jun 2026 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Tax liability | -0.76% | -313 | 40,987 | 05 Jun 2026 | Direct | ||
| Michelle L. Basil | HAE | Common Stock | Award | 70.4% | 28,424 | 68,829 | 15 May 2026 | Direct | ||
| Michelle L. Basil | HAE | Common Stock | Tax liability | -6.72% | -2,913 | 40,405 | 15 May 2026 | Direct | ||
| Frank Chan | HAE | Common Stock | Award | 509.8% | 27,535 | 32,936 | 15 May 2026 | Direct | ||
| Frank Chan | HAE | Common Stock | Tax liability | -9.18% | -546 | 5,401 | 15 May 2026 | Direct | ||
| James Darecca | HAE | Common Stock | Award | 116.6% | 29,312 | 54,444 | 15 May 2026 | Direct | ||
| James Darecca | HAE | Common Stock | Tax liability | -9.06% | -2,505 | 25,132 | 15 May 2026 | Direct | ||
| Farris Maryanne Maunsell | HAE | Common Stock | Award | 51.9% | 2,220 | 6,501 | 15 May 2026 | Direct | ||
| Farris Maryanne Maunsell | HAE | Common Stock | Tax liability | -4.4% | -197 | 4,281 | 15 May 2026 | Direct | ||
| Roy Galvin | HAE | Common Stock | Award | 223% | 27,535 | 39,882 | 15 May 2026 | Direct | ||
| Roy Galvin | HAE | Common Stock | Tax liability | -6.65% | -879 | 12,347 | 15 May 2026 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Award | 47.6% | 13,323 | 41,300 | 15 May 2026 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Tax liability | -3.28% | -948 | 27,977 | 15 May 2026 | Direct | ||
| Christopher Simon | HAE | Common Stock | Award | 21.4% | 78,344 | 444,704 | 15 May 2026 | Direct | ||
| Christopher Simon | HAE | Common Stock | Tax liability | -2.57% | -9,681 | 366,360 | 15 May 2026 | Direct | ||
| James Darecca | HAE | Common Stock | Tax liability | -2.32% | -655 | 27,637 | 01 May 2026 | Direct |
* marks a reported price that did not pass the local price check.